Filing Details
- Accession Number:
- 0001209191-17-046038
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-21 21:48:09
- Reporting Period:
- 2017-07-20
- Filing Date:
- 2017-07-21
- Accepted Time:
- 2017-07-21 21:48:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
873303 | Sarepta Therapeutics Inc. | SRPT | Pharmaceutical Preparations (2834) | 930797222 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1522780 | Md M. Edward Kaye | 215 First Street Suite 415 Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-07-20 | 4,349 | $40.93 | 62,471 | No | 4 | F | Direct | |
Common Stock | Disposition | 2017-07-20 | 10,000 | $41.00 | 52,471 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of restricted stock.
- This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on May 12, 2017, accordingly, the reporting person had no discretion with regards to the timing of the transaction.